Yingying Liu

Yingying Liu

Auto-generated profile, based on publicly available information

Yingying Liu

School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250014, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in World Journal of Gastroenterology
Verified
Journal Article
Open access
LDLi Duan
Li Duan
HYHua Yuan
Hua Yuan
CSChangjun Su
Changjun Su
YLYing-Ying Liu
Ying-Ying Liu
ZRZhi-Ren Rao
Zhi-Ren Rao
Ultrastructure of junction areas between neurons and astrocytes in rat supraoptic nuclei

23 December 2021 in Medicine
Verified
Journal Article
Open access
YGYing Gao
Ying Gao
YLYingying Liu
Yingying Liu
ZGZhaoan Guo
Zhaoan Guo
LZLei Zhang
Lei Zhang
To compare the efficacy and safety of calcineurin inhibitor (CNI) and Tripterygium wilfordii polyglycoside tablets (TWPs) in treating idiopathic membranous nephropathy (IMN) with CNI and glucocorticoids (GCs). Data of patients with IMN who were treated with CNI+TWPs (TWP group) or CNI+GCs (GC group) and followed up for more than 12 months at the Affiliated Hospital of Shandong University of Traditional Chinese Medicine from 2017 to 2020 were retrospectively analyzed. The 24-h urine protein (24hUP), serum albumin (ALB), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), serum creatinine, alanine aminotransferase, and aspartate transaminase levels on the third, sixth, ninth, and twelfth months of treatment and phospholipase A2 receptor (PLA2R) level before and after treatment were compared in both groups. We recruited 64 patients who were assigned to either the GC group (n = 31) or TWP group (n = 33). No difference in baseline indicators between the two groups were observed (P > .05). After 12 months, the 24hUP levels of both groups significantly decreased compared with that at baseline (P < .01). At the end of the sixth month, 24hUP of the TWP group were less and reduced more quickly than those in the GC group (P < .05), but there is no difference at the other time point (P > .05). After treatment, the number of patients who up to the standard of TG and the ALB levels in both groups increased (P < .05), the LDL-C levels and the number of patients positive for PLA2R in both groups were reduced (P < .05), and no significant difference was observed in the overall changes of 24hUP, ALB and LDL-C levels, TG compliance rate, and PLA2R positive rate between both groups (P > .05). During treatment, no patient in either group had hepatorenal dysfunction, one case in the TWP group and two cases in the GC group experienced side effects, but no apparent difference in the side effects were observed between both groups (P > .05). Two therapeutic schemes have the advantage of reducing urinary protein excretion in patients with IMN. Compared with CNI+GCs, CNI+TWPs have high efficiency and is widely applied, which might be considered as an optimum therapy in the future.

1 April 2021 in Clinical Nephrology
Verified
Journal Article
Closed access
DWDi Wang
Di Wang
YWYan Wang
Yan Wang
BLBaojian Liu
Baojian Liu
YLYingying Liu
Yingying Liu
SSShiren Sun
Shiren Sun
Electron microscopy (EM) was used to observe the deposition and ultrastructural characteristics of amyloids in abdominal adipose tissue, which provided a reliable basis for pathological diagnosis of systemic amyloidosis. 42 patients with established amyloidosis and 8 controls underwent surgical biopsy of subcutaneous abdominal fat. The fat tissues were submitted concurrently in 4% buffered neutral formalin for histological sections preparation, in glutaraldehyde fixative for EM studies, and in saline solutions for immunofluorescence tests. Light microscopy revealed marked brick-red staining in 11 of 42 samples, 6 moderate and 11 slight staining in the septum of cells, medium and small sized vessel, and apple green double refraction under polarized light microscopy. There were no significant differences in fat biopsies between the systemic amyloidosis and normal subjects in 14 cases. The EM showed approximate 10-nm-thick straight filaments in adipose tissue in all 42 cases with amyloidosis. The positive rate of diagnosis was 100%. Congo red stained sections alone in cases with scant amyloid led to false negative results, but the EM was able to characterize the amyloid protein in all cases. Therefore, preliminary diagnosis of suspected cases can be made by Congo red staining, but the final diagnosis requires an electron microscopic examination.

8 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
JYJie Yu
Jie Yu
YLYingying Liu
Yingying Liu
WGWeixing Guo
Weixing Guo
YLyunlun li
yunlun li
Objectives. Yishenjiangyafang is a traditional Chinese medicine used to clinically treat hypertension. This study aimed to explore the effect of yishenjiangyafang on plasma metabolomics in senile spontaneously hypertensive rats (SHRs). Methods. Twelve 50-week-old SHR (6 males and 6 females) were randomly divided into two groups: a treatment group, in which rats were intragastrically administered with yishenjiangyafang (10.08g kg−1·d−1), and a model group, in which all SHRs were administered the same volume of saline. Six age- and gender-matched WistarKyoto (WKY) rats were used as the control group. Treatment was given for 6 days per week and lasted for 8 weeks. Systolic and diastolic blood pressures of the rats were measured with the noninvasive tail artery pressure measurement system. An ultraperformance liquid chromatography quadruple electrostatic field orbit (UPLC-Q-Exactive) was used to determine metabolite changes in the plasma of SHR rats before and after yishenjiangyafang treatment in the treatment group as well as in the model and control groups. Results. After yishenjiangyafang treatment, SHRs had significant lower blood pressure. Using UPLC-Q-Exactive, we identified 26 metabolic targets of yishenjiangyafang in aged SHRs and revealed that yishenjiangyafang targeted four major metabolic pathways, linoleic acid metabolism, glycerophospholipid metabolism, arginine and proline metabolism, and steroid hormone biosynthesis. Conclusion. Yishenjiangyafang decreases the blood pressure of SHRs at least in part through targeting of four major metabolic pathways. Our study illustrates mechanisms underlying the clinical application of yishenjiangyafang in the treatment of hypertensive patients.